Anja von Hyderbreck;Guojun Yuan;Merck Patent GmbH;Jean-Marie Cuillerot;Pfizer, Inc.
发明人:
Jean-Marie Cuillerot,Anja von Heydebreck,Guojun Yuan
申请号：
US15553437
公开号：
US20180244781A1
申请日:
2016.02.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1.
